Setting a precedent: Development of a core outcome set for locoregional treatment outcome reporting in neoadjuvant breast cancer trials.
Stuart McIntosh(Queen's University Belfast), Shelley Potter(At Bristol), Sandra A. Finestone(Consumers Union), Anne Meyn(Patient Advocate Foundation), Jean L. Wright(University of North Carolina at Chapel Hill), O. Person(Sheba Medical Center), Nicholas Zdenkowski(Lake Macquarie Private Hospital), Mairead MacKenzie(The Patients Association), P. Poortmans(University of Antwerp), Kerry Avery(University of Bristol), Han‐Byoel Lee(Seoul National University Hospital), Jana de Boniface(Karolinska Institutet), Fiorita Poulakaki(Athens Medical Center), Peter Dubsky(Hirslanden Klinik St. Anna), Gustavo Werutsky(European Organisation for Research and Treatment of Cancer), Andrew J. Spillane(Melanoma Institute Australia), Alastair M. Thompson(Baylor College of Medicine), David Dodwell(University of Oxford), Hiroji Iwata(Aichi Cancer Center), Michael Jiang(University of Bristol)
Cited by 1
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Clinical Practice Guideline: Sudden Hearing Loss (Update)
|Otolaryngology|2019|918